Extract

This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.

Inclusion criteria

• Multiple sclerosis

Country

• Australia
• Austria
• Belgium
• Bulgaria
• Canada
• Czech Republic
• Finland
• France
• Germany
• Hungary
• Israel
• Italy
• Netherlands
• Poland
• Romania
• Russian Federation
• Serbia
• Spain
• Sweden
• Switzerland
• Ukraine
• United Kingdom
• United States

Links

• nct